Drug Profile
Tetravalent inactivated influenza vaccine - Zydus Cadila
Alternative Names: VaxiFlu - 4Latest Information Update: 11 Jul 2019
Price :
$50
*
At a glance
- Originator Zydus Cadila
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza virus infections
Most Recent Events
- 11 Jul 2019 Launched for Influenza virus infections (Prevention) in India before July 2019 (IM)
- 09 Oct 2017 Cadila Healthcare plans a registrational phase III trial for Influenza virus infections (Prevention, In infants, In children, In adolescents) in India (CTRI2017-08-009204)
- 24 Feb 2017 Registered for Influenza virus infections (Prevention) in India (IM) before February 2017